TIMELESS Antikörper (AA 72-1050)
Kurzübersicht für TIMELESS Antikörper (AA 72-1050) (ABIN8046818)
Target
Alle TIMELESS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- AA 72-1050
-
Verwendungszweck
- Anti-TIMELESS Antibody
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins
-
Produktmerkmale
- Anti-TIMELESS Antibody. Tested in ELISA, WB applications. This antibody reacts with Human.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human TIMELESS recombinant protein (Position: Q72-E1050).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Western blot, 0.25-0.5 μg/mL, Human ELISA, 0.1-0.5 μg/mL, -
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Konzentration
- 500 μg/mL
-
Buffer
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing. -
Haltbarkeit
- 12 months
-
-
- TIMELESS (Timeless Homolog (TIMELESS))
-
Andere Bezeichnung
- TIMELESS
-
Hintergrund
-
Background: The protein encoded by this gene is highly conserved and is involved in cell survival after damage or stress, increase in DNA polymerase epsilon activity, maintenance of telomere length, and epithelial cell morphogenesis. The encoded protein also plays a role in the circadian rhythm autoregulatory loop, interacting with the PERIOD genes (PER1, PER2, and PER3) and others to downregulate activation of PER1 by CLOCK/ARNTL. Changes in this gene or its expression may promote prostate cancer, lung cancer, breast cancer, and mental disorders.
Gene Full Name: timeless circadian regulator
-
Molekulargewicht
- 160 kDa
-
Gen-ID
- 8914
-
UniProt
- Q9UNS1
-
Pathways
- Protein targeting to Nucleus, Photoperiodism
Target
-